Get Started

HRMY

NASD Harmony Biosciences Holdings, Inc.
Nov 4, 2026 · 9:56 PM ET EOD Market Closed

$34.42 ↑ +0.00 (+0.00%) Trading Up from the previous close of $34.42, $1.56 below the day’s high of $35.97

YTD change
-8.03%
vs 20-day SMA
-9.49%
vs 200-day SMA
-0.83%

Price ranges

Previous day
$36.33 $38.75
open $37.97 close $37.02
-$0.95 (-2.50%)
Today
$32.61 $35.97
open $34.50 now $34.42
-$0.09 (-0.25%)
Past week
$36.33 $39.20
from $37.95 now $34.42
-$3.54 (-9.31%)
Past month
$34.11 $40.57
from $39.36 now $34.42
-$4.95 (-12.56%)
This year
$25.90 $43.49
from $37.42 now $34.42
-$3.01 (-8.03%)

Price & Performance

+1.82 (+5.60%) / 6M

$28.79$33.83$38.86$43.90May 4Aug 5Nov 4

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 44.6% away from all-time highs of $62.09
  • HRMY is down 8% since the beginning of the year
  • HRMY is up 12% over the past 12 months
  • HRMY is down 13% over the past 1 month
  • 11% of all HRMY investors are betting against HRMY

HRMY reads poor: price sits below both the 20- and 200-day averages, the 12-month move is +12.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $1.28
Earnings momentum -17.7% Quarterly EPS growth
Quarterly change -17.7%

Valuation

P/E ratio 12.27
Enterprise value $1.7B
Beta 1.46

Balance sheet & scale

Income$181.3K
Revenue$959.9M
Cash$667.8M
Debt$221.0K
Income / Debt 0.82×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $2.0B

Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company, which engages in the provision of development and commercialization of therapies for the treatment of neurological disorders. Its product, WAKIX, is a molecule with a novel mechanism of action designed to increase histamine signaling in the brain by binding to H3 receptors. The company was founded by Jeffrey S. Aronin on July 25, 2017 and is headquartered in Plymouth Meeting, PA.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,417.99 +0.61%
JNJ Johnson & Johnson $276.32 +3.81%
ABBV AbbVie, Inc. $294.83 +3.09%
MRK Merck & Co., Inc. $150.36 +3.93%
RHHBY Roche Holding Ltd Sponsored ADR $60.94 +2.97%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.